Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease

Thrombosis Research

Volumn 121, Issue 4, 2008, Pages 469-476

  Bereczky, Zsuzsanna ^a   Balogh, Emilia ^a   Katona, Éva ^a   Czuriga, István ^a   Kárpáti, Levente ^a   Shemirani, Amir H ^a   Édes, István ^a   Muszbek, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Coronary artery disease; Coronary sclerosis; Factor XIII; Factor XIII V34L polymorphism; Fibrinogen; Myocardial infarction

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; FIBRINOGEN; LEUCINE; VALINE;

ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CORONARY ARTERY DISEASE; CORONARY VESSELS; FACTOR XIII; FIBRINOGEN; GENOTYPE; HOMOZYGOTE; HUMANS; MYOCARDIAL INFARCTION; PROTEIN SUBUNITS; SCLEROSIS;

EID: 38749083796     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.05.012     Document Type: Article

References (44)

1. Muszbek L., Yee V., and Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 94 (1999) 271-304
2. Greenberg C.S., Sane D.C., and Lai T. Factor XIII and fibrin stabilization. In: Colman R.W., Marder V.J., Cloves A.W., George J.N., and Goldhaber S.Z. (Eds). Hemostasis and thrombosis. 5th edition (2006), Lippincott Williams and Wilkins, Philadelphia 317-334
3. Mikkola H., Syrjälä M., Rasi V., Vahtera E., Peltonen L., and Palotie A. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 84 (1994) 517-525
4. Kohler H.P., Stickland M.H., Ossei-Gerning N., Carter A., Mikkola H., and Grant P. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 79 (1998) 8-13
5. Wartiovaara U., Perola M., Mikkola H., Totterman K., Savolainen V., Penttila A., et al. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 142 (1999) 295-300
6. Franco R.F., Pazin-Filho A., Tavella A.H., Simões M.V., Marin-Neto J.A., and Zago M.A. Factor XIII Val34Leu and the risk of myocardial infarction. Haematologica 85 (2000) 67-71
7. Gemmati D., Serino M.L., Ongaro A., Tognazzo S., Moratelli S., Resca R., et al. A common mutation in the gene for coagulation factor XIII-A (Val34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 67 (2001) 183-188
8. Kakko S., Elo T., Tapanainen J.M., Huikuri H.V., and Savolainen M.J. Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest 32 (2002) 643-648
9. Reiner A.P., Heckbert S.R., Voss H.L., Ariens R.A.S., Lemaitre R.N., Smith N.L., et al. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Blood 102 (2003) 25-30
10. Hancer V.S., Diz-Kucukkaya R., Bilge A.K., Ozben B., Oncul A., Ergen G., et al. The association between factor XIII Val34Leu polymorphism and early myocardial infarction. Circ J 70 (2006) 239-242
11. Canavay I., Henry M., Morange P.E., Tiret L., Poirier O., Ebagosti A., et al. Genetic polymorphisms and coronary artery disease in the South of France. Thromb Haemost 83 (2000) 212-216
12. Corral J., González-Conejero R., Iniesta J.A., Riviera J., Martínez C., and Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 85 (2000) 293-297
13. Roldan V., Corral J., Marin F., Rivera J., Pineda J., Gonzalez-Conejero R., et al. Role of factor XIII Val34Leu polymorphism in patients < 45 years of age with acute myocardial infarction. Am J Cardiol 91 (2003) 1242-1245
14. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107 (2003) 1117-1122
15. Aleksic N., Ahn C., Wang Y.W., Juneja H., Folsom A.R., Boerwinkle E., et al. Factor XIIIA Val34Leu polymorphism does not predict risk of coronary artery disease: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 22 (2002) 348-352
16. Butt C., Zheng H., Randell E., Robb D., Parfrey P., and Xie Y.G. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction. Blood 101 (2003) 3037-3041
17. Vokó Z., Bereczky Z., Katona É., Ádány R., and Muszbek L. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb Haemost 97 (2007) 458-463
18. Boekholdt S.M., Sandhu M.S., Wareham N.J., Luben R., Reitsma P.H., and Khaw K.T. Fibrinogen plasma levels modify the association between the factor XIII Val34Leu variant and risk of coronary artery disease: the EPIC-Norfolk prospective population study. J Thromb Haemost 4 (2006) 2204-2209
19. Bereczky Z., Balogh E., Katona É., Pocsai Z., Czuriga I., Széles G., et al. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population. Thromb Res (2007) 10.1016/j.thromres. 2006. 12.013
20. Balogh I., Szo{double acute}ke G., Kárpáti L., Wartiovaara U., Katona E., Komaromi I., et al. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familiar thrombophilia. Blood 96 (2000) 2479-2486
21. Wartiovaara U., Mikkola H., Szo{double acute}ke G., Haramura G., Karpati L., Balogh I., et al. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost 84 (2000) 595-600
22. Ariens R.A., Philippou H., Nagaswami C., Weisel J.W., Lane D.A., and Grant P.J. The factor XIII V34L polymporhism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 96 (2000) 988-995
23. 2-antiplasmin incorporation into fibrin. Thromb Haemost 84 (2000) 1128-1130
24. Lim B.C.B., Ariens R.A.S., Carter A.M., Weisel J.W., and Grant P.J. Genetic regulation of fibrin structure and function complex gene-environment interactions may modulate vascular risk. Lancet 361 (2003) 1424-1431
25. Mannila M.N., Eriksson P., Ericsson C.G., Hamsten A., and Silveira A. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentrations, fibrin gel structure and risk of myocardial infarction. Thromb Haemost 95 (2006) 420-427
26. Kárpáti L., Penke B., Katona É., Balogh I., Vámosi G., and Muszbek L. A modified optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin Chem 46 (2000) 1946-1955
27. 2). Thromb Haemost 83 (2000) 268-273
28. Shemirani A.H., and Muszbek L. Rapid detection of the factor XIII Val34Leu (163G → T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis. Clin Chem Lab Med 42 (2004) 877-879
29. Bereczky Z., Balogh E., Katona É., Czuriga I., Édes I., and Muszbek L. Elevated factor XIII level is associated with an increased risk of myocardial infarction in women. Haematologica 92 (2007) 287-288
30. Ariens R.A., Kohler H.P., Mansfield M.W., and Grant P.J. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 19 (1999) 2012-2016
31. Kohler H.P., Ariens R.A.S., Whitaker P., and Grant P.J. A common coding polymorphism in the FXIII A-subunit gene (FXIIIVAL34LEU) affects cross-linking activity. Thromb Haemost 80 (1998) 704
32. Kohler H.P., Futers T.S., and Grant P.J. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Thromb Haemost 81 (1999) 511-515
33. Warner D., Mansfield M.W., and Grant P.J. Coagulation factor XIII and cardiovascular disease in the UK Asian patients undergoing coronary angiography. Thromb Haemost 85 (2001) 408-411
34. Muszbek L., Bereczky Z., and Katona É. Blood coagulation factor XIII: involvement in fibrinolysis and thrombosis. In: Arnout J., de Gaetano G., Hoylaerts M., Peerlinck K., Van Geet C., and Verhaeghe R. (Eds). Thrombosis. Fundamental and clinical aspects (2003), Leuven University Press, Leuven, Belgium 197-224
35. Chatterjee T., Schröder V., Windecker S., Meier B., and Kohler H.P. Venous and intracoronary factor XIII A-subunit antigen and activity levels are not associated with extent of coronary artery disease. J Thromb Haemost 1 (2003) 861-863
36. Mills J.D., Mansfield M.W., and Grant P.J. Factor XIII circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease. Thromb Haemost 87 (2002) 409-414
37. Warner D., Mansfield M.W., and Grant P.J. Coagulation factor XIII levels in UK Asian subjects with type 2 diabetes mellitus and coronary artery disease. Thromb Haemost 86 (2001) 1117-1118
38. Kohler H.P., Ariens R.A., Catto A.J., Carter A.M., Miller G.J., Cooper J.A., et al. Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy middle-age men. Br J Haematol 118 (2002) 825-832
39. Kienast J., Thompson S.G., Raskino C., Pelzer H., Fechtrup C., Ostermann H., et al. Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis. Thromb Haemost 70 (1993) 550-553
40. Szczeklik A., Musial J., Dropinski J., Krzanowski M., Krolikowski W., Undas A., et al. Thrombinogenesis and its pharmacological modulation in atherosclerosis. J Physiol Pharmacol 45 (1994) 3-11
41. Martinez-Sales V., Vila V., Reganon E., Goberna M.A., Ferrando F., Palencia M.A., et al. Elevated thrombotic activity after myocardial infarction: a 2-year follow-up study. Haemostasis 28 (1998) 301-306
42. Reganon E., Vila V., Martinez-Sales V., Vaya A., and Aznar J. Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction. Haematologica 87 (2002) 740-745
43. Janus T.J., Lewis S.D., Lorand L., and Shafer J.A. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Biochemistry 22 (1983) 6969-6972
44. Lewis S.D., Janus T.J., Lorand L., and Shafer J.A. Regulation of formation of factor XIIIa by its fibrin substrate. Biochemistry 24 (1985) 6772-6777